Tevogen Q2 FY26 net loss widens to $5.76 million; operating loss rises to $5.66 million

Reuters2026/08/14 21:19

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Tevogen posted a Q2 net loss of USD 5.76 million, widening from USD 5.5 million a year earlier.
Operating loss widened to USD 5.66 million from USD 5.44 million, with R&D expense rising 21.58% to USD 3.28 million.
G&A expense fell 13.29% to USD 2.38 million, due to lower legal and professional fees and stock-based compensation.
Cash totaled USD 1.1 million at June 30, 2026; management said liquidity covers at least 12 months with loan capacity and committed grants.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tevogen Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-038509), on August 14, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Tevogen Q2 FY26 net loss widens to $5.76 million; operating loss rises to $5.66 million

You may also like

Crypto prices